For several yearsn ow,h uman geneticists have been expecting that, with the availability of ad ense set of genetic markers across the genome and high-throughput genotyping technologies, genome-wide association studies will be feasible and will lead to the discovery of major genetic factorscontributing to susceptibility to common human diseases.B yc oordinated internationalefforts, areference humangenome sequence was determined and millionso fs ingle nucleotide polymorphisms (SNPs)w ere identified. Several million SNPs have been genotypedb yt he InternationalH apMap Consortium and the resultant HapMaps have been used to develop sets of markers that can be typed on high-throughput genotyping platformsat reasonable cost. Just as numerous genome-wide association studies to investigate an umber of complex traits are getting started, however, new developments in the field are forcing researcherst or e-think their strategy. Despite these complications, however, humang eneticists area lready coming up with strategies to address these problems, and thepapersfound in this issue of Human Genomics are representativeo ft his movement.
As Stranger and Dermitzakis point out in their review, susceptibility to many complex traits mayinvolvemultiple loci and their interactions with each other and the environment, often associated with altered gene regulation. They argue that, in additiont ot he genetic profile,o ne mayh avet oe xamine the gene expression patterns of the cases and controls in order to establish thel inks between genotype and phenotype. Because gene expression is often tissue specific and affected by environmental changes, patientr ecruitment and sample acquisition will be complicated. With newer expression arrays that study all of the exons in the genome,h owever, and a careful choiceo ft issues in these studies, gene expression data will probably be combined with SNP genotyping data in association studies in the future.
In ordert oi ncrease the chance of finding the 'major' genetic factorsi nvolved in ac ommon disease,t he phenotype of the cases (and controls) needs to be as homogeneous as possible.This is hard enough for most common diseases but it is especially difficult in the study of cancer,amulti-stage process. In their paper in this issue,S avage and Chanock describe the pitfalls in over-interpreting association study results in cancer studies and propose aw ay to move towards the goal of usingg enetic data in clinicalo ncology.A sb etter clinicald efinitions of diseases are used in patient collections, and as similar populations areu sed in replication studies, the chances of establishing 'real' associations will improve with time.
The recent finding that there are as ignificantn umber of structural variations in the human genome is makingh uman geneticists re-think the wayt hat association studies arec onducted. Becauset hese variations and polymorphisms (in the formofcopynumberv ariants, inversions, insertions, deletions and complex rearrangements of multiple kilobase regions) are difficult to detect and cause aberrant behaviour in SNP genotyping data, they pose ad ifficult problem for the experimentalist and statisticians alike. In this issue of the journal, Carson and colleagues describe the strategies one can use to detect structural variants and showt hat realisation of their presence in ac andidate region can help the researcherst oi nterpret seemingly confusing data to their benefit.
Av exing problem for those engaged in genome-wide studies is that false-positiver esults are the rule because of multiple testing with millions of markers. Hidden population structure mayr esult in genetic differences between the cases and controls that have nothing to do with disease status. This increases the chanceo fo btainingf alse-positive results in genome-wide studies. Moreover, it is ad ifficult problem to solvei ns tudies involving memberso fo ne ethnic group,s uch as those of Europeand escent. In their paper,L iu and Zhao describe an on-parametric strategy for addressing the issue of populations tructurea nd showt hat it performs well againsto ther methods designed to solve the same problem.
Additional help is found in the area of direct association studies based on al arge seto ff unctional SNPs across the genome.A sC arlton and colleagues reporti nt his issue, functional SNP-based studies are efficient because they focus on the SNPs with the highest likelihood of being responsible for the disease.C oupled with comparative genomics showing that functional elements tend to be found in conservedr egions, application of bioinformatics methods (see paper by vanD riel and Brunner) will soon enable one to design ac omprehensives et of functional SNPs for genome-wide direct association studies.
As the papersi nt his issue have shown, thesei ssues are being recognised and addressed in ways that give one hope that genome-wide association studies will begin to identify genetic factorsr esponsible for disease susceptibility.E xamples of genome-wide studies usingp romisinga pproaches are found in an umber of studies, including those on human ageing described herein by Kaeberlein. With deeper understandingo ft he occurrence of structural variations in the genome; the developmento fn ew tools to study them in association studies; new methods for thea ssessment of population structure and expression profiles; ac omprehensive set of functional SNPs;b etter defined patient samples; and appropriate design of replication studies, one can expect genome-wide association studies to bear fruit in the near future.
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